Current Management of Children with Appendicitis CIPESUR Meeting November 18, 2011 George W. Holcomb, III, M.D., MBA Surgeon-in-Chief Children’s Mercy.

Slides:



Advertisements
Similar presentations
Acute appendicitis – controversies over management revisited Joint Hospital Surgical Grand Round 27 th October 2012 KC Wong.
Advertisements

How I Do It Laparoscopic Fundoplication George W. Holcomb, III, M.D., MBA Children’s Mercy Hospital Kansas City, MO.
- a randomised multicenter study
The IPEG Annual Congress joins with:
Appendicitis: Current Management George W. Holcomb, III, M.D., MBA Children’s Mercy Hospital Kansas City, MO.
Ravi Vohra West Midlands Research Collaborative Clinical Variation in Practice of Laparoscopic Cholecystectomy and Surgical Outcomes: a multi-centre, prospective,
Middlemore Hospital, University of Auckland
How do we manage perforated Crohn’s Disease? Daniel von Allmen, MD Cincinnati Children’s Hospital Medical Center Cincinnati, Ohio.
Review: Treatment of Necrotizing Enterocolitis Cynthia D. Downard, Elizabeth Renaud, & Gudrun Aspelund On Behalf of APSA Outcomes & Clinical Trials Committee.
METHODS OF CLOSURE FOR GASTROSCHISIS AND OMPHALOCELE
Current Management of Children with Appendicitis George W. Holcomb, III, M.D., MBA Surgeon-in-Chief Children’s Mercy Hospital Kansas City, Missouri.
Elective Colorectal Resection – How to Hasten the Recovery? Dr. Lily Ng RHTSK.
Heidi Beck & Eva Yuen NUTN 514 February 11, 2008.
Current Management of Empyema George W. Holcomb, III, M.D., MBA Surgeon-in-Chief Children’s Mercy Hospital Kansas City, MO.
1 Lecture 20: Non-experimental studies of interventions Describe the levels of evaluation (structure, process, outcome) and give examples of measures of.
Complications During and After Restoration of Intestinal Continuity After Colostomy. Is it Worth it? Gustavo Plasencia, MD, FACS, FASCRS.
A Retrospective Analysis of the Impact of Intramuscular Antibiotics for the Treatment of ‘Borderline’ Foot Infections - an Admission Avoidance Strategy.
Evidence Based Medicine and Level 1 Outcomes Research in Pediatric Surgery George W. Holcomb, III, M.D., MBA Children’s Mercy Hospital Kansas City, Missouri.
George W. Holcomb, III, M.D., MBA Children’s Mercy Hospital
Long Term Clinical Outcome of 150 Consecutive Laparoscopic Nissen Fundoplications The Minimal Access Therapy Training Unit The Royal Surrey County Hospital,
Laparoscopic Nissen Fundoplication and Gastrostomy – How I Do It
Insert Program or Hospital Logo Introduction The Respiratory Syncytial virus (RSV) was discovered in 1956 and has been since recognized as one of the most.
Single Site Umbilical Laparoscopic Surgery (SSULS) George W. Holcomb, III, M.D., MBA Surgeon-in-Chief Children’s Mercy Hospital Kansas City, MO.
Dr.Mohammad foudazi Research center of endoscopic surgery, Iran medical university.
Shiva Sharma, Breast/Endocrine S.H.O.  Most common presentation requiring surgery  Great variability with regards to:  Timing  Choice  Route of administration.
Therapeutic Role of Oral Water Soluble Iodinated Contrast agent in Postoperative Small Bowel Obstruction.
Quality-of- life, Body Image and Cosmesis after Single Incision Laparoscopic Cholecystectomy (SILC) Versus Conventional Laparoscopic Cholecystectomy (CLC)
Improving Outcomes in Laparoscopic Appendicectomy (LA) E Dinneen, T Tilmann, J Preston, MS Nair, R Navaratnam. North Middlesex University Hospital, Sterling.
Advances in Pediatric MIS Over The Past Decade George W. Holcomb, III, M.D., MBA Surgeon-in-Chief Children’s Mercy Hospital Kansas City, Missouri.
Laparoscopic Pancreatectomy Attila Nakeeb, M.D., F.A.C.S. Department of Surgery Indiana University School of Medicine 7th Annual Symposium on Gastrointestinal.
Randomized Clinical Trial of Laparoscopic Versus Open Repair of the Perforated Peptic Ulcer: The LAMA Trial Marietta J. O. E. Bertleff, Jens A. Halm, Willem.
Laparoscopy for Splenic Conditions George W. Holcomb, III, M.D., MBA Surgeon-in-Chief Children’s Mercy Hospital Kansas City, Missouri.
Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.
Evidence Based Medicine R3 林雅慧 Clerks 翁瑄、楊畯棋 指導老師 : 駱至誠 醫師.
Peritonsillar Abscess: I&D vs Needle Aspiration Mandisa McIver, MD Cohen Children’s Medical Center of New York Pediatric Emergency Medicine.
Authors Institutions. Background  Rib fractures are the most common thoracic injury  Rib fractures are associated with an increase in hospital morbidity.
Management of Colonic Diverticulitis
RBC transfusions in critically ill patients TMR Journal Club March 1, 2007 Maggie Constantine.
Pectus Excavatum: The Kansas City Experience George W. Holcomb, III, M.D., M.B.A. Surgeon-in-Chief Children’s Mercy Hospital Kansas City, MO.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
VCU Department of Surgery Death & Complications Conference
In the name of god.  After endoscopy Semm introduced Laparoscopic Appendectomy(LA) in 1983  The use of it increased by in the management of acute appendicitis.
Racial disparities in hospital admissions and surgical management of children with appendicitis T. M. Bird Child Health Services Research Group Department.
Laparoscopic Treatment of Crohn’s Disease: Is It the Standard Approach? Steven D Wexner, MD, FACS, FRCS, FRCS (Ed) Chairman, Department of Colorectal Surgery.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
Validation and Refinement of a Prediction Rule to Identify Children at Low Risk for Acute Appendicitis Kharbanda AB, Dudley NC, Bajaj L, et al; Pediatric.
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
The Health Roundtable Postoperative IV Antibiotic Therapy for Children with Complicated Appendicitis: A Propensity Score-Matched Observational Study Presenter:
Integrated Management of Childhood Illnesses
Single Site Umbilical Laparoscopic Surgery (SSULS)
Interval Appendectomy
Important questions As good or better ? Cost effective ? Overall, safer? Is it safe as a cancer operation? Can all surgeons do it? Compare to open surgery.
Post-Appendectomy Bowel Obstruction Paige Mallette November 4, 2010.
Pediatric Small Bowel Obstruction: Can we learn from adults? Phillip A. Bilderback, MD Surgery Resident Virginia Mason Medical Center Seattle, WA.
Journal Club Management of Appendicitis
ANTIBIOTICS VERSUS APPENDECTOMY AS INITIAL TREATMENT FOR ACUTE APPENDICITIS Aileen Hwang, MD R2 Swedish Medical Center Department of General Surgery.
Aetiology of preoperative anaemia in patients undergoing elective cardiac surgery Jacob Abhrahm 1,Romi Sinha 2,Kathryn Robinson 3, David Cardone 1 1 Department.
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
Evidence Based Medicine and Level 1 Outcomes Research in Pediatric Surgery George W. Holcomb, III, M.D., MBA Children’s Mercy Hospital Kansas City, Missouri.
Antibiotics in the Management of Acute Appendicitis. Pediatric Surgery Cameron Gaskill January 3, 2013.
Appendicitis: Challenges in Management
Marina Yiasemidou, MBBS, MSc CT1 General Surgery
Non-operative management of “the” classic surgical disease?
Age and its Impact on Outcomes with Intraabdominal Infections
A new preoperative Severity Scoring System For Acute Cholecystitis
Decrease The Future Rate Of Dislocation?
Post-operative antibiosis for uncomplicated appendicitis
Interval Appendectomy: Evaluating the necessity and cost effectiveness
Chapter 7 The Hierarchy of Evidence
Aim and Key Driver Diagram
Presentation transcript:

Current Management of Children with Appendicitis CIPESUR Meeting November 18, 2011 George W. Holcomb, III, M.D., MBA Surgeon-in-Chief Children’s Mercy Hospital Kansas City, Missouri

Three Presentations Acute appendicitis % Perforated appendicitis % Perforated appendicitis with well- defined abscess (5-7 day history) %

Surgical History for Appendicitis (U.S.) 1990 – 2000 Slow adoption for laparoscopic approach Why –  Relatively small open incision (c/w splenectomy, fundoplication, cholecystectomy)  Many cases done middle of night – OR crews not used to laparoscopy  Benefits were not well appreciated

Surgical History for Appendicitis (U.S.) 2000 – 2010 Laparoscopic approach now favored (exclusively used at many centers including CMH) for all conditions: acute, perforated, abscess Why  Operative times improved – closure faster  Significantly fewer wound infections (almost none)  Improved cosmesis, esp if infection develops

Laparoscopic Appendectomy Personnel/Port Positions

Laparoscopic Appendectomy Technique Window in mesoappendix Vascular stapler across mesoappendix

Postoperative Appearance 3 Port Laparoscopic Appendectomy

Acute Appendicitis (No Perforation) April 2003 – Nov Pts – laparoscopic appendectomy 3 post-op abscesses (0.49%)

Acute Appendicitis Appendiceal Perforation Perforated appendicitis (3 - 5 day hx)  Evacuation/irrigation of purulent material  Wound problems minimized  20% post-op abscess rate

Laparoscopic Appendectomy Please use this link if you experience problems viewing the video above.this link

Laparoscopic vs Open Appendectomy Perforated Appendicitis Far fewer (almost none) wound infection with laparoscopic approach Allows surgeon to suction/irrigate under direct visualization Less postoperative SBO

Adhesive Small Bowel Obstruction After Appendectomy in Children: Comparison Between the Laparoscopic and Open Approach Jan 98-June 05: 1105 Appendectomies-447 Open, 628 Lap. AAP 2006 J Pediatr Surg 42: , 2007

Laparoscopic versus Open Appendectomy (1105 Patients) Laparoscopic (n = 628)Open (n = 477)P Value Age (years)11.0 +/ /- 5.1p > 0.05 Gender (M/F)355/273301/176p > 0.05 SBO1 (0.2%)7 (1.5%)p = 0.01 Perforated appendicitis Mean time to SBO8 days58 days Median follow-up (years)3.5 (0.8 – 6.5)4.9 (0.9 – 8.3) AAP 2006 J Pediatr Surg 42: , 2007

SBO After Perforated Appendicitis (378 Patients) LaparoscopicOpenp value Perforated appendicitis SBO1 (0.5%)6 (3.1%)p = 0.03 AAP 2006 J Pediatr Surg 42: , 2007

2000 – 2010 Questions 1)Do we operate in the middle of the night? 2)Is there an optimal antibiotic regimen for perforated appendicitis? 3)How do we define perforated appendicitis? 4)How do we manage the patient presenting with an abscess? 5)Which is better: SSULS or 3 port appendectomy?

1. When to Operate? Current Practice at CMH Patients identified with appendicitis are booked for laparoscopic appendectomy All receive a dose of rocephin (50mg/kg) and flagyl (30mg/kg) This antibiotic regimen was shown to be most cost effective in PRT If patients present at night, the operations are scheduled for the ‘surgeon of the week’ the next day (8 am or 1 pm start) Appendectomies rarely occur after 10 PM at night

Antibiotics Only vs Appendectomy For Non- Perforated Appendicitis Liu K, Ahanchi S, Pisaneschi M, et al. Can acute appendicitis be treated by antibiotics alone? Am Surg 73: , 2007 Retrospective comparative study (Level 3 study) in adults found no differences in complications between appendectomy at presentation or antibiotic therapy alone 5% recurrence rate

Early Operation Versus Delayed Operation Abou-Nukta F, Bakhos C, Arroyo K, et al. Effects of delaying appendectomy for acute appendicitis for 12 to 24 hours. Arch Surg 141: , 2006 Retrospective comparison in adults (Level 3 study) between operation 12 hours after presentation 308 patients No differences in OR time, complications, % with advanced appendicitis, or length of stay

Operation At Presentation Versus The Following Day Yardeni D, Hirschl RB, Drongowski RA, et al: Delayed versus immediate surgery in acute appendicitis: Do we need to operate during the night? J Pediatr Surg 39:464–469, Retrospective comparison in children (Level 3 study) between operation < 6 hrs after presentation or the following day 126 patients (38 early vs 88 late) No differences in operating time, perforation rate, or complications

The remaining four questions can be answered from studies at Children’s Mercy

5 – Expert opinion, or applied principles from physiology, basic science, or other conditions 4 – Case series or poor quality case control and cohort studies 3 – Case control studies 2 – Review of case control or cohort studies with agreement or poor quality randomized trial 1 – Prospective, randomized controlled trials Levels Of Evidence

2. Is There an Optimal Antibiotic Management for Perforated Appendicitis?

Prior to 2000, most pediatric centers in the U.S. were treating patients with intraabdominal infections with Ampicillin, Gentamicin and Clindamycin (Triple Antibiotic Therapy) Triple antibx provide good coverage; inexpensive But Gentamicin known to be toxic to hearing and renal function Serum levels recommended for Gentamicin use

Same broad spectrum coverage as triples The duo of Ceftriaxone and Metronidazole require no serum levels Ceftriaxone and Metronidazole has been shown to be safe and effective in once/day dosing Daily dosing allows easy transition to outpatient IV therapy, if needed Why Not Use Ceftriaxone/Metronidazole? Advantages

Retrospective Review 250 patients w/perforated appendicitis Those treated with Ceftriaxone/Metronidazole were compared to those treated with triple antibiotic coverage (Ampicillin, Gentamicin, Clindamycin) Retrospective Study (Level 3 study) Parameters included temperature curves for the first 5 post-operative days, abscess rate, length of hospitalization, length of intravenous antibiotic treatment and medication charges CAPS, 2005 J Pediatr Surg 41: , 2006

Retrospective Results Retrospective Results Outcomes WBC (x10 3 ) 9.8 +/ / LOS (Days) 6.8 +/ / IV Tx (Days)7.2 +/ / Abscess (%) 8.8% 14.2% 0.37 C/MA/G/C P Value CAPS, 2005 J Pediatr Surg 41: , 2006

Results Results Temperature Curves Admission Post-Operative Days Tmax (Degrees Celsius) C/M A/G/C * * * * * * P < CAPS, 2005 J Pediatr Surg 41: , 2006

Results Results Medication Charges Expense of dose ($ dose) = (drug price + dispensing charge ) Expense of course = ($ dose) x (# doses/day) x (days of treatment) CAPS, 2005 J Pediatr Surg 41: , 2006

Results Results Medication Charges Ceftriaxone Dose Charge = ( $ $28.13 ) Expense of Course = ($47.51) x (1 dose/day) x (7 days) = $332 Ampicillin Dose Charge = ( $ $28.13 ) Expense of Course = ($28.51) x (4 doses/day) x (7 days) = $798 Impact Of Nursing Charges CAPS, 2005 J Pediatr Surg 41: , 2006

Results Medication Charges $ of Course C/MA/G/C P Value < $ /- $29.34 $ /- $78.44 CAPS, 2005 J Pediatr Surg 41: , 2006.

With this information, is there any reason to perform a prospective randomized trial comparing Ceftriaxone/Metronidazole to Triple Antibiotic Therapy (Ampicillin, Gentamicin, Clindamycin) for perforated appendicitis?

Why A Prospective, Randomized Trial? Why A Prospective, Randomized Trial? Weaknesses Retrospective Uneven numbers between groups Postoperative care not standardized Recent experience vs historical experience creates bias  Far more laparoscopy in recent cohort (C/M)  (47% in C/M group vs 2% in A/G/C group)  Experience w/laparoscopy improved  Pressures to discharge sooner in recent cohort independent of medication regimen?

Prospective Randomized Trial Ceftriaxone/Metronidazole or A/G/C Perforated appendicitis at the time of appendectomy  Hole in the appendix  Visible appendicolith in the abdomen Power 0.8; alpha 0.05; sample size 100 Exclusion Criteria Known allergy to one of the medications

Standardized Management All patients receive 5 days IV antibiotics Diet begins after flatus WBC drawn on POD 5 Nl WBC count and tolerating PO’s w/o fever meets discharge criteria If elevated, draw again on POD 7, then if elevated, draw on POD 10 and obtain CT No antibiotics on discharge

Results Results Outcomes WBC (x10 3 ) 9.4 +/ / LOS (Days) / / IV Tx (Days) 6.0 +/ / Abscess (%) 20.4% 16.3% 0.79 C/MA/G/C P Value AAP, 2007 J Pediatr Surg 43:79-82, 2007

Results Results Medication Charges Total Meds $3370 $ % of Med Charges 4.5% 6.1% <0.001 C/MA/G/C P Value IV Abx $1412 $1940 <0.001 AAP, 2007 J Pediatr Surg 43: , 2008

Triples C/M Admission Post-Operative Day Max Temeperature (Degrees Celsius ) Results Temperature Curves AAP, 2007 J Pediatr Surg 43: , 2008

Conclusions There is no difference in infectious complications, recovery or defervescence after perforated appendicitis between Ceftriaxone/Metronidazole and Triples (A/G/C) Ceftriaxone/Metronidazole is more cost- effective than standard triple antibiotic therapy AAP, 2007 J Pediatr Surg 43: , 2008

The literature is replete with retrospective studies regarding perforated appendicitis All of these studies fail to strictly define perforation  Dependent on surgeon’s definition  “Gangrenous”, “suppurative”, “perforated” Therefore, the conclusions from these retrospective reports must be approached cautiously 3.How Do We Define Perforated Appendicitis?

J Pediatr Surg 43: , 2008 J Pediatr Surg 43: , 2008

Post-operative Antibiotic Regimen For Perforated Appendicitis In Children: A Prospective Randomized Trial April November patients To ensure accurate data, the two groups had to be equal and a definition had to be created

Visible appendicolith Hole in appendix Definition of Perforation Used in Prospective Randomized Trial

Hypothesis A correct definition of perforation (DOP) is important because  Provides us with the information to safely and efficiently treat patients  Allows us to better identify which patients are at risk for developing postoperative complications If our definition of perforation was correct  There should be no increase in abscess rate in the cohort of patients treated as non-perforated appendicitis after the definition was used If our definition of perforation was incorrect  There should be an increase in abscess rate in the cohort of patients treated as non-perforated appendicitis after the definition was used (b/c of under-treatment)

Results Outcomes NON- Perforated Prior DOP (n=292) After DOP (n=388) Abscess rate1.7%0.8% LOS (days)1.9 +/ /- 1.5 Perforated Prior DOP (n=131) After DOP (n=161) Abscess rate14.0%18% LOS (days)9.4 +/ /- 8.8 PAPS 2008 J Pediatr Surg 43: , 2008 J Pediatr Surg 43: , 2008

Conclusions Our strict DOP (either a visible hole in the appendix or appendicolith in the abdomen) has been shown to be safe  No increase in abscess rate for non-perforated patients  No detectable risk of under treating patients defined as non- perforated This DOP will improve overall care for children with appendicitis  Eliminate unnecessary antibiotic treatment  Improve cost management  Simplify treatment protocols  Improve the integrity of clinical data  Allow for ongoing clinical research PAPS 2008 J Pediatr Surg 43: , 2008

4.How do we manage the child presenting with an abscess due to ruptured appendicitis?

Perforated Appendicitis Presenting With Abscess Open operation for abscess is difficult Percutaneous drainage has been described and applied Laparoscopy is being used to treat perforated appendicitis and abscess Which is better? History

Perforated Appendicitis with Abscess 1)5 - 7 day history 2)Dehydrated – needs IVF 3)Percutaneous drainage (interventional radiology) 4)PICC line - antibiotics 5)Discharge day 3-5 if stable 6)Antibiotics con’t days at home 7)Return 8-10 wk. for interval appendectomy (to prevent recurrent appendicitis) - overnight hospitalization

Retrospective Experience with Interval Appendectomy 52 patients – Total hospital days = 7.0 +/- 3.9 Total healthcare visits = 7.6 +/- 2.8 Total number of CT scans = 3.5 +/- 2.0 Recurrent Abscess = 10 pts (19.2%) AAP, 2007 J Pediatr Surg 43: , 2008

Perforated Appendicitis with Abscess Perforated Appendicitis with Abscess Prospective Trial Drainable abscess OR for laparoscopic appendectomy vs percutaneous drainage as initial management Drain groups undergoes laparoscopic appendectomy at 10 weeks. Quality of life surveys at admission, at 2 weeks and at 12 weeks Pilot study – 40 patients APSA 2009 J Pediatr Surg 45: , 2010

Initial Non-Op Mgmt vs Lap Appendectomy in Children Presenting with an Abscess APSA 2009 J Pediatr Surg 45: , 2010 Patient Characteristics at the Time of Admission Initial operation (n=20) Initial nonoperative management (n=20) P Age (y)10.1 ± ± Weight (kg)37.0 ± ± Body mass index (kg/cm 2 )18.0 ± ± White blood cell count17.4 ± ± Maximum temperature37.8 ± ± Maximum axial area of abscess (cm 2 ) 29.2 ± ± Values are expressed as mean ± SD

Initial Non-Op Mgmt vs Lap Appendectomy in Children Presenting with an Abscess APSA 2009 J Pediatr Surg 45: , 2010 Outcomes Comparing Initial Operation and Initial Abscess Drainage Followed by Interval Appendectomy Initial operation (n = 20) Initial nonoperative management (n = 20) P Operation time (min)62.1 ± ± Total length of hospitalization (d)6.5 ± ± Recurrent abscess after initial treatment (%) 20%25%1.0 Doses of narcotics9.7 ± ± Total health care visits2.8 ± ± 1.0<.001 No. of CT scans1.5 ± ± Total charges$44,195 ± $19,384$41,687 ± $18, Values are expressed as mean ± SD, unless otherwise indicated

Prospective Randomized Trial Conclusion – There is no difference b/w initial laparoscopic operation vs initial non-operative management followed by laparoscopic interval appendectomy Management can be determined by the surgeon’s preference and experience APSA 2009 J Pediatr Surg 45: , 2010

5.Is there an advantage performing the laparoscopic appendectomy through a single umbilical incision?

SSULS Appendectomy

Please use this link if you experience problems viewing the video above.this link

Postoperative Appearance

Prospective Randomized Trial 360 total patients Acute non-perforated appendicitis August 09 – November 10 Primary outcome variable – postoperative wound infection Standardized pre and postoperative management Quality of life surveys at 6 weeks and 6 months Single Umbilical Incision vs 3-Port Laparoscopic Appendectomy

Patient Characteristics at Operation Single Incision (N=180) 3-Port (N=180) P-value Age (yrs)11.05 ± ± Weight (kg)42.7 ± ± Gender (% male)54.4%51.1%0.53 Leukocyte count14.7 ± ± American Surgical Assn – 2011 Ann Surg 254: , 2011

Outcome Data Single Incision (N=180) 3-Port (N=180) P- value Wound Infection3.3%1.7%0.50 Operative Time (mins)35.2 ± ± 11.6<0.001 Postoperative Length of Stay (hours) 22.7 ± ± Hospital Charges ($)17.6K ± 4.0K16.5 ± 3.8K0.005 American Surgical Assn – 2011 Ann Surg 254: , 2011

Summary There have been significant changes in the surgical management of appendicitis These changes have revolved around timing of surgery and the almost exclusive use of the laparoscopic approach Unclear if appendicitis will be a surgical disease in the future

QUESTIONS